🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
No prospective randomized trials have evaluated the most efficacious dose o...
Status
Completed
Location
Dartmouth Hitchcock Medical Center
Start Date
2013-12
Trial ID
NCT02139280
Treatments Being Tested
This is a phase I, prospective clinical trial studying the safety and feasi...
Status
Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2025-09-25
Trial ID
NCT07052370
RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07-28
Trial ID
NCT00309842
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184
Background: Blood cancers (such as leukemias or lymphomas) often do not re...
Status
Recruiting
Location
City of Hope
Start Date
2022-11-18
Trial ID
NCT05436418
The goal of this clinical research study is to learn if it is possible to c...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-08-22
Trial ID
NCT01329900
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
MBCCOP - University of South Alabama
Start Date
1998-09
Trial ID
NCT00003416
RATIONALE: Giving chemotherapy, natural killer cells, aldesleukin, and tota...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2006-02
Trial ID
NCT00354172
This is a single-institution, phase II study to determine the event-free su...
Status
Completed
Location
University of Minnesota Masonic Cancer Center and Medical Center
Start Date
2016-03
Trial ID
NCT02582775
This study will be a single-center treatment protocol, designed to validate...
Status
Completed
Location
Wilmot Cancer Institute
Start Date
2015-10
Trial ID
NCT02660281